“A large, Phase 3 study testing a Covid-19 vaccine being developed by AstraZeneca and the University of Oxford at dozens of sites across the U.S. has been put on hold due to a suspected serious adverse reaction in a participant in the United Kingdom,” Stat reports.
“The nature of the adverse reaction and when it happened was not immediately known, though the participant is expected to recover.”
Save to Favorites